Evaluation of common genetic variants in vitamin E-related pathway genes and colorectal cancer susceptibility

• DOI: 10.1007/s00204-021-03078-0
• Publication Date: 2021-05-19T11:02:43Z
• Authors: Qiuyi Zhang; Yixuan Meng; Mulong Du; Shuwei Li; Junyi Xin; Shuai Ben; Zhengdong Zhang; Dongying Gu; Meilin Wang
• Keywords: 03 medical and health sciences; 0302 clinical medicine; Case-Control Studies; Humans; Vitamin E; Genetic Predisposition to Disease; Transcriptional Elongation Factors; Colorectal Neoplasms; Polymorphism, Single Nucleotide; 3. Good health

Vitamin E is effective for preventing the risk of cancer. However, few studies have elucidated the mechanism of vitamin E in cancer occurrence. Herein, we aimed to identify the genetic variants in vitamin E-related pathway genes associated with colorectal cancer risk. We applied logistic regression models to assess the association between single-nucleotide polymorphisms (SNPs) in vitamin E-related pathway genes and colorectal cancer risk in the Chinese and European population. The false discovery rate (FDR) method was used to correct multiple comparisons. The mRNA and protein expression analysis were evaluated in public database and in-house RNA-Seq data. SCARB1 rs73227586 was identified significantly increased risk of colorectal cancer in the Chinese population (odd ratio (OR) = 1.46, 95% confidence interval (CI) = 1.22-1.75, P = 2.99 × 10-5). This finding was further validated in the European population (OR = 1.11, 95% CI = 1.02-1.20, P = 1.44 × 10-2). Additionally, the mRNA and protein expression of SCARB1 were markedly up-regulated in colorectal tumor tissues. Moreover, rs73227586 T allele could increase the minimum free energy (MFE) and weaken binding ability to transcription factor ELL2. Our findings indicated that SCARB1 may play a carcinogenic role in colorectal cancer. Genetic variants in vitamin E-related pathway genes may concern to be predictors of colorectal cancer risk.